.
Australian Pharmaceutical Industries (ASX:API) has swung to an interim profit after reporting a loss of $115 million the year before.
The owner of the Priceline chain generated a net profit of $21.3 million in the six months to the end of February while underlying profit grew 32 per cent to $16.2 million.
Australian Pharmaceutical has attributed the performance to earnings growth from its core business, a stronger financial position and disciplined cost control.
Looking ahead the company believes business momentum will continue for the remainder of the 2015 financial year.
A fully franked interim dividend of 2 cents per share has been declared.
- Forums
- ASX - By Stock
- News: Australian Pharmaceutical swings to profit
{"streaming_server":"rtmp:\/\/s2svek4dh1hfyu.cloudfront.net\/cfx\...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add API (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online